このエントリーをはてなブックマークに追加
ID 35000
file
creator
Harada, Toshihide
Ishizaki, Fumiko
Horie, Nobuko
Nitta, Yumiko
Yamada, Tohru
Sasaki, Tomohiro
Nagakane, Tomoomi
Yasumatsu, Yoshiteru
Nitta, Kohsaku
Katsuoka, Hiroyuki
subject
Parkinson's disease
Depression
Pramipexole
UPDRS
MADRS
HAMD
NDC
Medical sciences
abstract
Previous studies have shown that pramipexole might have the potential to improve depressive symptoms in patients with Parkinson's disease. To provide more evidence, in five Japanese patients at Hoehn & Yahr stage 1-3 we evaluated the Unified Parkinson's Disease Rating Scale (UPDRS), Hamilton Depression Rating Scale (HAMD) and Montgomery Asberg Depression Rating Scale (MADRS) at our hospital. After the pramipexole treatment, each total score of UPDRS, HAMD and MADRS significantly decreased compared with that before the treatment. Our data indicate that pramipexole improves depressive symptoms in patients with Parkinson's disease.
journal title
Hiroshima Journal of Medical Sciences
volume
Volume 60
issue
Issue 4
start page
79
end page
82
date of issued
2011-12
publisher
Hiroshima University Medical Press
issn
0018-2052
ncid
language
eng
nii type
Departmental Bulletin Paper
HU type
Departmental Bulletin Papers
DCMI type
text
format
application/pdf
text version
publisher
rights
(c) Hiroshima University Medical Press.
department
Graduate School of Biomedical Science
他の一覧